Premium formula for menstrual cycle symptoms support
- Supports menstrual regularity
- Promotes hormonal balance
- Helps maintain and balanced mood
It is uncertain what exactly causes premenstrual syndrome, but several factors may contribute to the condition—cyclic changes in hormones, chemical changes in the brain, and even depression. However, what is well-known is that many women experience many unpleasant symptoms before, during and/or after their menstrual period, and during menopause with both emotional and physical symptoms.
Fem Balance’s™ compound of vitamins, adaptogenic herbs, and other nutrients help relieve some of the mental and emotional changes as well as mild physical symptoms experienced prior to and during the menstrual cycle and in menopause. These symptoms include irritability, moodiness, fatigue, insomnia, bloating, and hot flashes. Fem Balance helps to provide an emotional and mental calming effect while helping to balance hormones and regulate the menstrual cycle.
Natural substances such as vitamins B6, B12, folate, chaste berry, Ashwagandha, and Rhodiola, have proven effective in supporting emotional as well as physical health during the menstrual cycle.
Fem Balance™, containing all these well-researched ingredients, is formulated in doses that effectively provide healthy menstrual support, offer an emotional and mental calming effect, and help balance hormones and regulate the menstrual cycle.
Fem Balance™ is your go-to, premium supplement to support and regulate the symptoms of the menstrual cycle.
Fem Balance™ combines vitamins and herbs that help provide mood support during regular menstrual cycles.*
AOR™ guarantees that all ingredients have been declared on the label. Made without wheat, gluten, peanuts, sulfites, soy, dairy, eggs, fish, shellfish or any animal by-product.
Take 2 capsules once a day with or without food, or as directed by a qualified health care practitioner. Do not take immediately before bed. Use for a minimum of 3 months for menstrual cycle support.
Consult your physician before use if you are pregnant, lactating, have a medical condition, or are taking any medication. Keep out of reach of children.
CAUTION: Consult a health care practitioner prior to use if you are, taking hormone containing medication such as progesterone preparations, oral contraceptives or hormone replacement therapy (HRT) or antidepressant medication.
- Supports menstrual regularity
- Promotes hormonal balance
- Supports mood
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
†Daily Value not established
Other Ingredients: Microcrystalline cellulose, Capsule (hypromellose, glycerin and purified water), Maltodextrin and Silicon dioxide.
Adlercreutz H, Fotsis T, Bannwart C, et al. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 1986;25:791-7.
Adlercreutz H, Heikkinen R, Woods M, et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 1982;2:1295-9.
Allais G, Bussone G, De Lorenzo C, Mana O, Benedetto C. Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects. Neurol Sci. 2005 May;26 Suppl 2:s125-9.
Burdette JE, Liu J, Chen SN, Fabricant DS, Piersen CE, Barker EL, Pezzuto JM, Mesecar A, Van Breemen RB,Farnsworth NR, Bolton JL. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem. 2003 Sep 10;51(19):5661-70.
Burke BE, Olson RD, Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharmacother. 2002 Aug;56(6):283-8.
Cheng, G., Wilczek, B., Warner, M., Gustafsson, J-A., Landgren, B-M. Isoflavone treatment for actue menopausal symptoms. Menopause Vol 13, No 3, 468-473.
Erkkola R, Vervarcke S, Vansteelandt S, Rompotti P, De Keukeleire D, Heyerick A. A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts.Phytomedicine. 2010 May;17(6):389-96.
Heyerick A, Vervarcke S, Depypere H, Bracke M, De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas. 2006 May 20;54(2):164-75.
Ferrante F, Fusco E, Calabresi P, Cupini LM (2004). Phytooestrogens in the prophylaxis of menstrual migraine. Clin Neuropharmacol 27:137–140
Kapiotis S, Hermann M, Held I, et al. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 1997;17:2868-74.
Marini, H., Minutoli, L., Polito, F., Bitto, A., Altavilla, D. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women. Ann Intern Med 2007: 146:839-847.
Messina, M., Wood, C. Soy Isoflavones, estrogen therapy, and breast cancer risk: Analysis and commentary. Nutrition Journal 2008, 7:17
Powell SL, Gödecke T, Nikolic D, Chen SN, Ahn S, Dietz B, Farnsworth NR, van Breemen RB, Lankin DC, Pauli GF, Bolton JL. In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent. J Agric Food Chem. 2008 Dec 24;56(24):11718-26.
Qiu SX, Dan C, Ding LS, Peng S, Chen SN, Farnsworth NR, Nolta J, Gross ML, Zhou P. A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways. Chem Biol. 2007 Jul;14(7):860-9.
Wang C, Makela T, Hase T, et al. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 1994;50:205-12.
Williamson-Hughes, P., Flickinger, B., Messina, M., Empie, M. Isoflavone supplements containing predominately genistein reduce hot flash symptoms: a critical review of published studies. Menopause. Vol 13, No 5, 831-839.